KBI Biopharma is headed to Washington D.C. for the 2025 WCBP Symposium this January!
Schedule a meeting >>
Meet with the KBI Biopharma Team:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
WCBP is an annual symposium recognized for addressing the role of current and emerging CMC analytical technology within evolving US and international regulatory perspectives. It brings together industry, regulatory, and academic professionals to discuss these topics.